2007•Chinese Journal of PharmaceuticalsRequires access

Bioequivalence of Paracetamol/Caffeine Orally Disintegrating Tablets in Healthy Volunteers

Jinsong Ding

Open publisher page 0 citations

Abstract

According to a randomized cross-over design,the bioequivalence of paracetamol/caffeine orally disin-tegrating tablets(test preparation) and its conventional tablets(reference preparation) in eighteen healthy volunteers were investigated.The plasma con centration of paracetamol and caffeine were determined by HPLC.After oral administration of paracetamol 500mg and caffeine 65mg,the main pharmacokinetic parameters of paracetamol for test preparation and reference preparartion were cmax(8450±1300) and(9350±1870)μg/L,tmax(0.6±0.3) and(0.7±0.3)h,AUC0→24(32680± 7550) and(31280±6570)μg.h.L–1,the main pharmacokinetic parameters of caffeine for test preparation and reference preparartion were cmax(1649±303) and(1659±272)μg/L,tmax(0.6±0.1) and(0.6±0.1)h,AUC0→24(10711±2743) and(10384±2948)μg.h.L–1.The relative bioavailability of orally disintegrating tablets was(105.1±13.8)% with paracetamol and(100.7±10.1)% with caffeine.The results of ANOVA analysis showed that the test and reference preparations were bioequivalent.

About this research paper

What this paper is about

According to a randomized cross-over design,the bioequivalence of paracetamol/caffeine orally disin-tegrating tablets(test preparation) and its conventional tablets(reference preparation) in eighteen healthy volunteers were investigated.The plasma con centration of paracetamol and caffeine were determined by HPLC.After oral administration of paracetamol 500mg and caffeine 65mg,the main pharmacokinetic parameters of paracetamol for test preparation and reference preparartion were cmax(8450±1300) and(9350±1870)μg/L,tmax(0.6±0.3) and(0.7±0.3)h,AUC0→24(32680± 7550) and(31280±6570)μg.h.L–1,the main pharmacokinetic parameters of caffeine for test preparation and reference preparartion were cmax(1649±303) and(1659±272)μg/L,tmax(0.6±0.1) and(0.6±0.1)h,AUC0→24(10711±2743) and(10384±2948)μg.h.L–1.The relative bioavailability of orally disintegrating tablets was(105.1±13.8)% with paracetamol and(100.7±10.1)% with caffeine.The results of ANOVA analysis showed that the test and reference preparations were bioequivalent.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

According to a randomized cross-over design,the bioequivalence of paracetamol/caffeine orally disin-tegrating tablets(test preparation) and its conventional tablets(reference preparation) in eighteen healthy volunteers were investigated.The plasma con centration of paracetamol and caffeine were determined by HPLC.After oral administration of paracetamol 500mg and caffeine 65mg,the main pharmacokinetic parameters of paracetamol for test preparation and reference preparartion were cmax(8450±1300) and(9350±1870)μg/L,tmax(0.6±0.3) and(0.7±0.3)h,AUC0→24(32680± 7550) and(31280±6570)μg.h.L–1,the main pharmacokinetic parameters of caffeine for test preparation and reference preparartion were cmax(1649±303) and(1659±272)μg/L,tmax(0.6±0.1) and(0.6±0.1)h,AUC0→24(10711±2743) and(10384±2948)μg.h.L–1.The relative bioavailability of orally disintegrating tablets was(105.1±13.8)% with paracetamol and(100.7±10.1)% with caffeine.The results of ANOVA analysis showed that the test and reference preparations were bioequivalent.

Key concepts: Bioequivalence, Caffeine, Cmax, Bioavailability, Pharmacokinetics, Chemistry, Pharmacology, Oral administration

Related papers

Back to paper searchBrowse research topicsOriginal source
Bioequivalence of Paracetamol/Caffeine Orally Disintegrating Tablets in Healthy Volunteers — Research Paper | ScholarLens